Evidence map›Paper›PMID 19803785›Full record

ArticleJournal of neurotrauma2010

Metabolic acetate therapy for the treatment of traumatic brain injury.

Peethambaran Arun, Prasanth S Ariyannur, John R Moffett, Guoqiang Xing, Kristen Hamilton, Neil E Grunberg, John A Ives, Aryan M A Namboodiri

Open access · greenAbstract read
In one paragraph

Article in Journal of neurotrauma, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Acetate enhances neuronal plasticity and reduces ischemic brain injury by promoting tau protein lactylation.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Tracing the path of disruption:CNS neuroscience & therapeutics · 2024
    Review
  8. Review
  9. Article
  10. Brain, behavior, & immunity - health · 2023
    Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Peethambaran ArunDepartment of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814, USA.
Prasanth S Ariyannur
John R Moffett
Guoqiang Xing
Kristen Hamilton
Neil E Grunberg
John A Ives
Aryan M A Namboodiri
Uniformed Services University of the Health Sciences · USSamueli Institute · US

Funding

CANAVAN DISEASE PATHOGENESIS AND TREATMENTR01NS039387 · NINDS · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI NAMBOODIRI, ARYAN MANGALAM · 2000 to 2002
$534k
NINDS NIH HHS NS R01/R56; 039387
6 · The paper itself

Abstract

Patients suffering from traumatic brain injury (TBI) have decreased markers of energy metabolism, including N-acetylaspartate (NAA) and ATP. In the nervous system, NAA-derived acetate provides acetyl-CoA required for myelin lipid synthesis. Acetate can also be oxidized in mitochondria for the derivation of metabolic energy. In the current study, using the controlled cortical impact model of TBI in rats, we investigated the effects of the hydrophobic acetate precursor, glyceryltriacetate (GTA), as a method of delivering metabolizable acetate to the injured brain. We found that GTA administration significantly increased the levels of both NAA and ATP in the injured hemisphere 4 and 6 days after injury, and also resulted in significantly improved motor performance in rats 3 days after injury.

Indexed as

AcetatesAcetic AcidAcetyl Coenzyme AAnimalsAspartic AcidBrainBrain InjuriesDisease Models, AnimalEnergy MetabolismLipid MetabolismMaleMembrane LipidsMyelin SheathNeuroprotective AgentsRatsRats, Sprague-DawleyAcetatesAcetic AcidAcetyl Coenzyme AAspartic AcidMembrane LipidsN-acetylaspartateNeuroprotective AgentsTriacetin

Identifiers

PMID19803785
PMCPMC2824219
OpenAlexW2023704083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.